Chinese artificial cornea product launched with 97.8% sight restoration rate-中国人工角膜产品上市，复明率可达97 8% скачать в хорошем качестве

Chinese artificial cornea product launched with 97.8% sight restoration rate-中国人工角膜产品上市，复明率可达97 8%

China State Drug Administration website news, December 7, the State Drug Administration after review, approved the Beijing Mih medical device limited liability company production of innovative products "artificial cornea" registration. The product consists of a lens post and a stent. The lens post is made of polymethyl methacrylate. The stent is composed of titanium stent wings and polymethylmethacrylate stent holders. The product is sterilized by ethylene oxide and is for single use. It is suitable for patients with bilateral corneal blindness where corneal transplantation is difficult to succeed, including corneal transplantation failure, severe corneal conjunctival scar vascularization caused by chemical injury, thermal burn, explosion injury, etc., eyelid atresia, severe autoimmune diseases (such as Stevens-Johnson syndrome and scar-like aspergillosis), corneal blindness caused by end-stage dry eye, etc. According to the State Drug Administration, the product is made from artificial materials and does not require donor corneas, helping to alleviate the scarcity of corneal donors. The product adopts a split design and a staged implantation procedure, in which the artificial corneal stent is implanted between the patient's damaged corneal layers and anchored to the surrounding corneal tissue; the artificial corneal lens post is fixed in the patient's eye by screwing into the stent using a threaded structure, reducing the risk of injury to the affected eye from the implantation procedure and helping to improve the product's incidence. The posts can be removed or replaced when necessary. The product offers a new approach to the clinical treatment of patients who are contraindicated to traditional corneal transplantation.